UnitedHealth Group
UNH (NYSE)
UnitedHealth Group stands out as the largest health insurer in the U.S., demonstrating resilience with stable cash flows and strong performance during economic downturns like the one in 2022. With a dividend yield of approximately 3.06%, it remains an attractive choice for income-seeking investors despite recent challenges, including a 1-year return of -38.08%. Analysts maintain a favorable outlook, with a median 12-month price target of $390.50, reflecting confidence in the company’s long-term value.
Pros:
- Largest US health insurer
- Stable cash flows
Cons:
- Recent stock performance decline
- Revenue outlook below analyst expectations
UnitedHealth Group (UNH) may be suitable for income-focused investors looking for stability in the health insurance sector, particularly those willing to weather short-term volatility given its recent performance. With a solid dividend yield and a positive long-term outlook from analysts, it could represent a strategic addition to a diversified investment portfolio, especially for those prioritizing cash flow over immediate capital gains.